It is commonly associated with MS (119), although it is also a common feature of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and neuromyelitis optica spectrum disorders (NMOSD) (120). The gene discussed is MOG; the disease is neuromyelitis optica.